332 related articles for article (PubMed ID: 23054316)
1. The lipid story in chronic kidney disease: a long story with a happy end?
Kujawa-Szewieczek A; Więcek A; Piecha G
Int Urol Nephrol; 2013 Oct; 45(5):1273-87. PubMed ID: 23054316
[TBL] [Abstract][Full Text] [Related]
2. Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.
Rysz J; Gluba-Brzózka A; Banach M; Więcek A
Int Urol Nephrol; 2015 May; 47(5):805-13. PubMed ID: 25758011
[TBL] [Abstract][Full Text] [Related]
3. Statins for treatment of dyslipidemia in chronic kidney disease.
Shurraw S; Tonelli M
Perit Dial Int; 2006; 26(5):523-39. PubMed ID: 16973506
[TBL] [Abstract][Full Text] [Related]
4. Is lipid management effective for all stages of CKD?
Ku E; Campese V
Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
[TBL] [Abstract][Full Text] [Related]
5. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
[TBL] [Abstract][Full Text] [Related]
6. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
Ponte B; Bourquin V; Stoermann-Chopard C
Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemia in Patients with Kidney Disease.
Thobani A; Jacobson TA
Cardiol Clin; 2021 Aug; 39(3):353-363. PubMed ID: 34247749
[TBL] [Abstract][Full Text] [Related]
8. Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations.
Vaziri ND; Norris KC
Blood Purif; 2013; 35(1-3):31-6. PubMed ID: 23343544
[TBL] [Abstract][Full Text] [Related]
9. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment?
Scarpioni R; Ricardi M; Melfa L; Cristinelli L
Cardiovasc Ther; 2010 Dec; 28(6):361-8. PubMed ID: 20553296
[TBL] [Abstract][Full Text] [Related]
10. Dyslipidemia, statins, and CKD patients' outcomes - review of the evidence in the post-sharp era.
Heymann EP; Kassimatis TI; Goldsmith DJ
J Nephrol; 2012; 25(4):460-72. PubMed ID: 22641572
[TBL] [Abstract][Full Text] [Related]
11. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
Barylski M; Nikfar S; Mikhailidis DP; Toth PP; Salari P; Ray KK; Pencina MJ; Rizzo M; Rysz J; Abdollahi M; Nicholls SJ; Banach M;
Pharmacol Res; 2013 Jun; 72():35-44. PubMed ID: 23542730
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia in patients with chronic kidney disease.
Hager MR; Narla AD; Tannock LR
Rev Endocr Metab Disord; 2017 Mar; 18(1):29-40. PubMed ID: 28000009
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease.
Peev V; Nayer A; Contreras G
Curr Opin Lipidol; 2014 Feb; 25(1):54-60. PubMed ID: 24345987
[TBL] [Abstract][Full Text] [Related]
14. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
15. Statins and renal disease: friend or foe?
Deshmukh A; Mehta JL
Curr Atheroscler Rep; 2011 Feb; 13(1):57-63. PubMed ID: 21053107
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based statin prescription for cardiovascular protection in renal impairment.
Fabbian F; De Giorgi A; Pala M; Tiseo R; Manfredini R; Portaluppi F
Clin Exp Nephrol; 2011 Aug; 15(4):456-63. PubMed ID: 21556807
[TBL] [Abstract][Full Text] [Related]
17. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
Kanbay M; Turgut F; Covic A; Goldsmith D
J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
[TBL] [Abstract][Full Text] [Related]
18. Lipid management in patients with chronic kidney disease.
Ferro CJ; Mark PB; Kanbay M; Sarafidis P; Heine GH; Rossignol P; Massy ZA; Mallamaci F; Valdivielso JM; Malyszko J; Verhaar MC; Ekart R; Vanholder R; London G; Ortiz A; Zoccali C
Nat Rev Nephrol; 2018 Dec; 14(12):727-749. PubMed ID: 30361677
[TBL] [Abstract][Full Text] [Related]
19. Statins in the management of dyslipidemia associated with chronic kidney disease.
Epstein M; Vaziri ND
Nat Rev Nephrol; 2012 Feb; 8(4):214-23. PubMed ID: 22349484
[TBL] [Abstract][Full Text] [Related]
20. Statins in chronic kidney disease and kidney transplantation.
Kassimatis TI; Goldsmith DJ
Pharmacol Res; 2014 Oct; 88():62-73. PubMed ID: 24995940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]